Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides

Nature Biotechnology

Volumn 17, Issue 11, 1999, Pages 1097-1100

  Taylor, Jennifer K ^a   Zhang, Qing Qing ^a   Wyatt, Jacqueline R ^a   Dean, Nicholas M ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

Alternative splicing; Antisense oligonucleotide; Apoptosis; Bcl x

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA PRECURSOR; PROTEIN BCL X;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; ULTRAVIOLET B RADIATION;

ALTERNATIVE SPLICING; APOPTOSIS; BCL-X PROTEIN; BLOTTING, NORTHERN; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0003826861     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/15079     Document Type: Article

References (32)

1. Raff, M. Cell suicide for beginners. Nature 396, 119-122 (1998).
2. White, E. Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1-15 (1996).
3. Jiang, Z-H. & Wu, J.Y. Alternative splicing and programmed cell death. Proc. Soc. Exp. Biol. Med. 220, 64-72 (1999).
4. Boise, L.H. et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608 (1993).
5. Yang, E. & Korsmeyer, S.J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88, 386-401 (1996).
6. Kelekar, A. & Thompson, C.B. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8, 324-330 (1998).
7. Gonzalez-Garcia, M. et al. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA 92, 4304-4308 (1995).
8. Shiraiwa, N. et al. An additional form of rat Bcl-x, Bcl-xβ, generated by an unspliced RNA, promotes apoptosis in promyeloid cells. J. Biol. Chem, 271, 13258-13265 (1996).
9. Ban, J., Eckhart, L., Weninger, W., Mildner, M. & Tschachler, E. Identification of a human cDNA encoding a novel Bcl-x isoform. Biochem. Biophys. Res. Commun. 248, 147-152 (1998).
10. Reed, J.C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer chemoresistance. Curr. Opin. Oncol. 7, 541-546 (1995).
11. Taylor, J.K. & Dean, N.M. Regulation of pre-mRNA splicing by antisense oligonucleotides. Curr. Opin. Drug Discovery Dev. 2, 147-151 (1999).
12. Kole, R. Modification of pre-mRNA splicing by antisense oligonucleotides. Acta Biochim Pol. 44, 231-238 (1997).
13. Hodges, D. & Crooke, S.T. Inhibition of splicing of wild-type and mutated luciferase adenovirus pre-mRNAs by antisense oligonucleotides. Mol. Pharmacol. 48, 905-918 (1995).
14. Dominski, Z. & Kole, R. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 90, 8673-8677 (1993).
15. Sierakowska, H., Sambade, M.J., Agrawal, S. & Kole, R. Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 93, 12840-12844 (1996).
16. Dunckley, M.G., Manoharan, M., Villiet, P., Eperon, I.C. & Dickson, G. Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum. Mol. Genet. 5, 1083-1090 (1998).
17. Dean, N.M. & Griffey, R.H. Identification and characterization of second-generation antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 7, 229-233 (1997).
18. Taylor, J.K., Zhang, Q.Q., Monia, B.P., Marcusson, E.G. & Dean, N.M. Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Oncogene 18, 4495-4504 (1999).
19. Noble, J.R., Willetts, K.E., Mercer, W.E. & Reddel, R.R. Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53. Exp. Cell Res. 203, 297-304 (1992).
20. Yu, K. et al. Ras-dependent apoptosis correlates with persistent activation of stress-activated protein kinases and induction of isoform(s) of Bcl-x. Cell Death Differ. 4, 745-755 (1997).
21. Clarke, M.F. et al. A recombinant bcl-xS adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc. Natl. Acad. USA 92, 11024-11028 (1995).
22. Sumantran, V.N., Ealovega, M.W., Nunez, G., Clarke, M.F. & Wicha, M.S. Overexpression of Bcl-xS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res. 55, 2507-2510 (1995).
23. Ealovega, M.W., McGinnis, P.K., Sumantran, V.N., Clarke, M.F. & Wicha, M.S. Bcl-xS gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Res. 56, 1965-1969 (1996).
24. Harris, A.L. & Hochhauser, D. Mechanisms of multidrug resistance in cancer treatment. Acta Oncol. 31, 205-213 (1992).
25. Minn, A.J., Boise, L.H. & Thompson, C.B. Bcl-xS antagonizes the protective effects of Bcl-xL. J. Biol. Chem. 271, 6306-6312 (1996).
26. Tao, W., Kurschner, C. & Morgan, J.I. Bcl-xS and Bad potentiate the death suppressing activities of Bcl-xL, Bcl-2, and A1 in yeast. J. Biol. Chem. 273, 23704-23708 (1998).
27. Ray, S. et al. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis. Cell Growth & Differ. 7, 1617-1623 (1996).
28. Pena, J.C., Fuchs, E. & Thompson, C.B. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth & Differ. 8, 619-629 (1997).
29. Fridman, J.S., Rehemtulla, A., Hofmann, A., Blau, H.M. & Maybaum, J. Expression of Bcl-XS alters cytokinetics and decreases clonogenic survival in K12 rat colon carcinoma cells. Oncogene 17, 2981-2991 (1998).
30. Monia, B.P. et al. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 267, 19954-19962 (1992).
31. Condon, T.P. & Bennett, C.F. Altered mRNA splicing and inhibition of E-selectin by an antisense oligonucleotide in human umbilical vein endothelial cells. J. Biol. Chem. 271, 30398-30403 (1996).
32. Schwandner, R., Wiegmann, K., Bernardo, K., Kreder, D. & Kronke, M. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 273, 5916-5922 (1998).